An Update on FDAs Critical Path Initiative Statistical Contributions Robert T. ONeill Ph.D. Director, Office of Biostatistics Center for Drug Evaluation.
Molecular profiling 2013
Genomics experimental-methods
Adaptive Designs Working Group Adaptive Designs Logistic, Operational and Regulatory Issues Judith Quinlan Biopharm Statistics Leader Drug Discovery Sciences.
